Rafael León

1 ta ish

Spanish National Research Council

1. KEAP1‐NRF2 protein–protein interaction inhibitors: Design, pharmacological properties and therapeutic potential

   Enrique Crisman, Pablo Duarte, E. Daudén +4

   Sharh maqola20222 iqtibos

   ABIABI:AkademIndex/2026.other.282546